Cancer / Immunology
Innovent's IBI351 gets NMPA breakthrough designation for advanced colorectal carcinoma
This BTD for IBI351 was based on the pooled analysis of two ongoing clinical trials (NCT05005234, NCT05497336), which include 54 CRC pa...
May 15, 2023 | News
LaNova licenses novel cancer drug to AstraZeneca
LaNova Medicines Ltd. ("LaNova Medicines") announced it has entered into an exclusive license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN), for LM-305,...
May 15, 2023 | News
CytoMed collaborates with MD Anderson to advance Gamma Delta T Cells in Oncology
CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary techno...
May 11, 2023 | News
SHL Medical and MoonLake Immunotherapeutics collaborate to develop sonelokimab autoinjector
Sonelokimab is MoonLake Immunotherapeutics' investigational anti-IL-17 A/F Nanobody technology designed to more directly target sites of inflammation and p...
May 11, 2023 | News
Thermo Fisher & Pfizer team up to bring cancer testing to global markets
Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access t...
May 10, 2023 | News
Hummingbird Bioscience to showcase preclinical proof of concept for novel autoimmune disease antibody
HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutini...
May 09, 2023 | News
Telix to Provide Illuccix® to Bayer for Global Phase III Prostate Cancer Study, Including Japan
This global study is investigating the efficacy of Bayer's androgen receptor inhibitor (ARi) darolutamide plus androgen deprivation therapy (ADT) versus AD...
May 08, 2023 | News
Agilent and Theragen Bio Partner to Advance Bioinformatic Solutions for Cancer Genomic Profiling in South Korea
Agilent Technologies Inc. (NYSE: A) announced the recent signing of a Memorandum of Understanding (MOU) with Theragen Bio in South Korea to ...
April 26, 2023 | News
Gene Solutions' multi-cancer early detection shows promise in Southeast Asia's biotech industry.
Circulating tumor DNA, or cell-free tumor DNA (ctDNA) assay is based on detecting the appearance of ctDNA in blood. This method is sometimes called Liquid ...
April 26, 2023 | News
SCG Cell Therapy to Highlight Promising Antitumor and Antiviral Activities of SCG101 in Treating HBV-Related Hepatocellular Carcinoma at ISCT
"These exciting new data being presented at ISCT continue to reinforce the potential for viral antigen specific TCR-T product to effectively treat infectio...
April 24, 2023 | News
CARsgen's CT041 receives IND clearance from NMPA for pancreatic cancer therapy.
Dr Raffaele Baffa, Chief Medical Officer of CARsgen, commented that "We are glad to receive the IND clearance from NMPA for the adjuvant treatment of ...
April 20, 2023 | News
Samyang Holdings partners with LG Chem for innovative cancer therapeutics.
Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement on Thursday, April 20th, for development of nove...
April 20, 2023 | News
Anixa Biosciences and Cleveland Clinic Present Positive Data for Phase 1 Study of Breast Cancer Vaccine
Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer announced that Clev...
April 18, 2023 | News
BioSenic Granted Key European Patent for Therapeutic Development in Cancer and Immune Diseases
BioSenic’s new formulation lowers the dosage of arsenic trioxide by combining it with copper salts to ma...
April 18, 2023 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
